Skip to main content

Table 2 Follow-up of infants treated by cART for at least 3 months (ANRS-PEDIACAM Study, 2008–2013, Cameroon)

From: Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

  N = 167
M3 visit M12 visit M24 visit
  % (n) % (n) % (n)
Dead 0.0 (0) 5.3 (9)a 2.4 (4)b
Visit not performed 20.4 (34) 23.4 (39) 29.1 (64)
Visit performed 79.6 (133) 71.3 (119) 48.5 (81)
 Viral load (cp/mL)    
  < 400 35.3 (59) 52.7 (88) 34.1 (57)
 [400-1000] 15.6 (26) 4.8 (8) 3.6 (6)
  ≥ 1000 36.5 (61) 18.0 (30) 9.6 (16)
 not measured 12.6 (18) 24.5 (41) 59.3 (88)
Accompanied by:    
 Mother 79.0 (105) 73.1 (87) 71.6 (58)
Grandmother 8.3 (11) 8.4 (10) 8.6 (7)
 Aunt 5.9 (8) 5.9 (7) 5.0 (4)
 Other 6.8 (9) 12.6 (15) 14.8 (12)
Questionnaire completed N = 151 N = 126 N = 126
Questionnaire completed and viral load measured N = 144 N = 125 N = 67
  1. cART combined antiretroviral therapy, N total number, Mx delay from ART initiation to the current visit, e.g. «M3» means «3 months after cART initiation», % percentage; n number of patients in the cell
  2. a<12 months
  3. b12 to 24 months